All episodes

Moderator: Roland Wiest (Bern, Switzerland)
Guest: Randolf Klingebiel (Bielefeld, Germany)

In this episode, Roland Wiest and Randolf Klingebiel explore rare causes of myelopathy, a challenging condition due to its infrequent occurrence and diverse origins. They discuss the diagnostic workup, imaging protocols, and differential diagnoses, emphasizing the importance of collaboration between neurologists and neuroradiologists in managing these complex cases.

Moderator: Raphael Wurm (Vienna, Austria)
Guest: Majda Thurnher (Vienna, Austria)

For this episode, Raphaela Wurm welcomes Majda Thurnher to dive into the challenges and joys of diagnosing spinal cord ischemia as they explore MRI protocols, key imaging findings, and the impact of diffusion-weighted imaging.

Moderator: Raphael Wurm (Vienna, Austria)
Guest: Dr. Wolfgang Marik (Vienna, Austria)

In this episode, Raphael Wurm and Wolfgang Marik explore key neuroimaging techniques for the spine, focusing on when to use CT, MRI, myelography, and spinal arteriography. They discuss how to choose the right technology and address common challenges that can be avoided with proper indications.

EAN moderator: Youssuf Saleh (Oxford, United Kingdom)
Guest: Sebastiaan Engelborghs (Brussel, Belgium)

In this episode Youssuf Saleh and Sebastiaan Engelborghs discuss dementia prevention, with particular reference to the recently published lancet commission report on dementia prevention, intervention and care. Key areas of discussion include what those risks are, how they can be mitigated and what adaptations the field of neurology and public health need to minimise the burden of dementia in aging populations.

EAN moderator: Marian Galovic (Zurich, Switzerland)

Guest: Michel van Putten (Enschede, The Netherlands)
In this episode, Marian Galovic talks with Prof. Michel van Putten about the effects of cardiac arrest on the brain. They highlight the role of EEG in assessing long-term prognosis following cardiac arrest and discuss the treatment of rhythmic or periodic EEG patterns.

Moderator: Federica Agosta (Milan, Italy)
Guest: Philip van Damme (Leuven, Belgium)
In this week’s episodes Federica Agosta hosts Philip van Damme as they discuss the new EAN Guideline on the Management of Amyotrophic Lateral Sclerosis. Find more information here.

EAN moderator: Youssuf Saleh (Oxford, United Kingdom)
Guest: Thanh Doan (Trondheim, Norway)

For this episodes Youssuf Saleh is joined by Thanh Doan as they discuss the role of brain circuits in neuroscience and how they can be used to advance both our understanding of disease and lay foundations for circuit-based treatments including neuromodulation.

EAN Moderator: Melinda Magyari (Copenhagen, Denmark)

Special Moderator: Brett Drummond (Melbourne, Australia)

Guest: Susana Otero (Barcelona, Spain)
In this episode eanCast: Weekly Neurology is joined by The ECTRIMS Podcast. Hosts Melinda Magyari and Brett Drummond talk about the ECTRIMS-EAN Vaccination Consensus Statement with lead author Susana Otero. Find the full article here.

Moderator: Melinda Magyari (Copenhagen, Denmark)

Guest: Celia Oreja-Guevara (Madrid, Spain)
In this last August episode Melinda Magyari hosts Celia Oreja-Guevara as they explore the impact of MS on women's fertility, the shift in advice regarding pregnancy, and how pregnancy affects MS activity. They also discuss the importance of consulting a neurologist, considerations for artificial reproduction techniques, and recommendations for disease-modifying therapies, including treating relapses during pregnancy and breastfeeding.

Moderator: Melinda Magyari (Copenhagen, Denmark)

Guest: Thomas Berger (Vienna, Austria)

Melinda Magyari and her guest Thomas Berger talk about how aging affects MS progression and management, focusing on immunosenescence's impact on the immune response and DMT effectiveness. They cover the rise of comorbidities in older MS patients, the challenges of using DMTs over age 55, the lack of clinical trials for this age group, and share lifestyle tips to improve quality of life and health outcomes.